A phase II study of neoadjuvant bevacizumab and radiation therapy for resectable soft tissue sarcomas.

被引：0
|
作者：
Yoon, S. S. [1 ]
Chen, Y. [1 ]
Karl, D. [1 ]
Choy, E. [1 ]
Harmon, D. C. [1 ]
Kambadakone, A. [1 ]
Sahani, D. [1 ]
Duda, D. G. [1 ]
Jain, R. K. [1 ]
DeLaney, T. F. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.10023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10023
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Gene expression identifies heterogeneity of soft tissue sarcomas.
    Skubitz, K. M.
    Pambuccian, S.
    Skubitz, A. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 538S - 538S
  • [32] Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
    Brian Schulte
    Nisha Mohindra
    Mohammed Milhem
    Steven Attia
    Steven Robinson
    Varun Monga
    Angela C. Hirbe
    Peter Oppelt
    John Charlson
    Irene Helenowski
    Susan Abbinanti
    Rasima Cehic
    Scott Okuno
    Brian A. Van Tine
    Mark Agulnik
    British Journal of Cancer, 2021, 125 : 528 - 533
  • [33] Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
    Schulte, Brian
    Mohindra, Nisha
    Milhem, Mohammed
    Attia, Steven
    Robinson, Steven
    Monga, Varun
    Hirbe, Angela C.
    Oppelt, Peter
    Charlson, John
    Helenowski, Irene
    Abbinanti, Susan
    Cehic, Rasima
    Okuno, Scott
    Van Tine, Brian A.
    Agulnik, Mark
    BRITISH JOURNAL OF CANCER, 2021, 125 (04) : 528 - 533
  • [34] RESULTS OF MULTIMODALITY THERAPY OF RESECTABLE SOFT-TISSUE SARCOMAS OF THE RETROPERITONEUM
    GLENN, J
    SINDELAR, WF
    KINSELLA, T
    GLATSTEIN, E
    TEPPER, J
    COSTA, J
    BAKER, A
    SUGARBAKER, P
    BRENNAN, MF
    SEIPP, C
    WESLEY, R
    YOUNG, RC
    ROSENBERG, SA
    SURGERY, 1985, 97 (03) : 316 - 325
  • [35] Neoadjuvant therapy for soft tissue sarcomas - Does it make a difference?
    Scoggins, Charles R.
    CANCER, 2008, 112 (11) : 2338 - 2340
  • [36] Soft tissue sarcomas. A need for organising the pattern of referral
    El-Helw, LM
    Lorigan, PC
    Goepel, J
    Robinson, MH
    BRITISH JOURNAL OF CANCER, 1998, 78 : 42 - 42
  • [37] Retroperitoneal soft tissue sarcomas: A pilot study of intraoperative radiation therapy
    Bussieres, E
    Stockle, EP
    Richaud, PM
    Avril, AR
    Kind, MM
    Kantor, G
    Coindre, JM
    Bui, BN
    JOURNAL OF SURGICAL ONCOLOGY, 1996, 62 (01) : 49 - 56
  • [38] Neoadjuvant Chemotherapy and Hypofractionated Radiation Therapy in High-Grade Extremity Soft Tissue Sarcomas
    Silva, M. L. G.
    Spencer, R. M.
    Aguiar, S., Jr.
    Stevanato, P. R.
    Takahashi, R. M.
    Bezerra, T. S.
    Kupper, B. E. C.
    Mello, C. A.
    da Cunha, I. W.
    Pellizzon, C.
    Lopes, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E758 - E758
  • [39] A phase I dose-escalation study of azacitidine in combination with temozolomide in patients with soft tissue sarcomas.
    Matushansky, I.
    Coakley, K. E.
    Uldrick, T. S.
    Taub, R. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation therapy oncology group trial 9514
    Kraybill, WG
    Harris, J
    Spiro, IJ
    Ettinger, DS
    DeLaney, TF
    Blum, RH
    Lucas, DR
    Harmon, DC
    Letson, GD
    Eiaberg, B
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 619 - 625
12345